BeStock  
Stocks › Biotechnology › IBRX

ImmunityBio IBRX

US equityMarket cap rank #1801BiotechnologyTop Gainers Yesterday
$6.02 −$0.55 (-8.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.08 +1.08%
Open$6.41
Prev close$6.57
Day range$6.00 – $6.53
Volume10.64M
Market cap$6.40B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$48.84M+52.3% YoY
Operating profit-$77.99M-40.2% YoY
Net profit-$184.57M-174.3% YoY
Diluted EPS-$0.18-157.1% YoY
Free cash flow-$78.26M-12.3% YoY
Operating cash flow-$75.33M

Revenue, last 8 quarters

$7.6MDec '24$16.5MMar '25$26.4MJun '25$32.1MSep '25$38.3MDec '25$44.2MMar '26$51.2MJun '26$48.8MSep '26

Net profit, last 8 quarters

$-59.2MDec '24$-129.7MMar '25$-92.6MJun '25$-67.3MSep '25$-62.0MDec '25$-632.8MMar '26$-230.4MJun '26$-184.6MSep '26

Diluted EPS by quarter

-0.09Dec '24-0.15Mar '25-0.10Jun '25-0.07Sep '25-0.06Dec '25-0.62Mar '26-0.22Jun '26-0.18Sep '26

Free cash flow by quarter

$-87.3MDec '24$-87.0MMar '25$-80.8MJun '25$-69.7MSep '25$-71.7MDec '25$-77.1MMar '26$-70.0MJun '26$-78.3MSep '26

Annual revenue

$605.0KFY20$934.0KFY21$240.0KFY22$622.0KFY23$14.7MFY24$113.3MFY25

Profitability & balance sheet

Gross margin98.8%
Operating margin-150.2%
Net margin-607.8%
Return on assets-196.7%
Current ratio4.27
Liabilities / assets288.0%
Cash & investments$334.33M
Total debt$862.21M
Net cash (debt)-$527.88M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Product revenue, net$48.74M 99.8%
  • Other revenues$104,000.00 0.2%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $48.84M $51.24M $44.21M $113.29M $38.29M
Total Operating Revenue $48.84M $51.24M $44.21M $113.29M $38.29M
Cost of Revenue $1.29M $298,000.00 $238,000.00 $753,000.00 $382,000.00
Gross Profit $47.55M $50.94M $43.97M $112.54M $37.90M
Operating Expense $125.54M $112.64M $113.76M $368.56M $102.59M
Selling and Admin Expenses $54.00M $51.82M $45.77M $150.00M $38.73M
Research & Development $71.54M $60.82M $67.99M $218.56M $63.86M
Operating Profit -$77.99M -$61.70M -$69.79M -$256.03M -$64.68M
Net Non-Operating Interest Income (Expense) -$28.84M -$28.09M -$27.73M -$109.84M -$28.61M
Non-Operating Interest Income $3.17M $3.16M $736,000.00 $2.69M -$1.42M
Non-Operating Interest Expense $32.02M $31.24M $28.46M $112.53M $27.19M
Other Income (Expense) -$77.74M -$140.60M -$535.27M $14.26M $31.20M
Gain on Sale of Security -$17.33M -$44.88M -$292.73M $59.20M $33.06M
Other Non-Operating Income (Expenses) -$60.40M -$95.72M -$242.54M -$44.95M -$1.86M
Pretax Profit -$184.57M -$230.39M -$632.79M -$351.61M -$62.09M
Tax $0.00 $0.00 $9,000.00 -$135,000.00 -$135,000.00
Net Profit -$184.57M -$230.39M -$632.80M -$351.47M -$61.96M
Profit from Continuing Operations -$184.57M -$230.39M -$632.80M -$351.47M -$61.96M
Minority Interests -$15,000.00 -$12,000.00 -$15,000.00 -$74,000.00 -$14,000.00
Net Income to Parent Company -$184.55M -$230.38M -$632.78M -$351.40M -$61.94M
Net Income to Common Stockholders -$184.55M -$230.38M -$632.78M -$351.40M -$61.94M
Basic EPS -$0.17 -$0.22 -$0.62 -$0.38 -$0.06
Diluted EPS -$0.18 -$0.22 -$0.62 -$0.38 -$0.06
Earnings from Equity Interest – – – $0.00 –
Special Income (Charges) – – – $0.00 –
-Less:Impairment of Capital Assets – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $609.39M $628.50M $646.64M $501.90M $501.90M
Total Current Assets $418.79M $438.98M $452.95M $314.88M $314.88M
Cash and Cash Equivalents & Short-Term Investments $334.33M $357.37M $380.88M $242.82M $242.82M
-Cash and Cash Equivalents $45.08M $75.67M $205.19M $88.33M $88.33M
-Short Term Investments $289.25M $281.70M $175.69M $154.48M $154.48M
Receivables $53.61M $53.50M $43.27M $42.62M $42.62M
-Accounts Receivable $53.60M $53.47M $43.27M $42.57M $42.57M
-Due from Related Parties Current $13,000.00 $27,000.00 $3,000.00 $46,000.00 $46,000.00
Prepaid Assets $1.56M $1.35M $25.23M $26.40M $26.40M
Inventory $6,000.00 $1.94M $547,000.00 $910,000.00 $910,000.00
Other Current Assets $29.28M $24.82M $3.02M $2.14M $2.14M
Total Non-Current Assets $190.60M $189.52M $193.68M $187.02M $187.02M
Net PPE $142.66M $145.49M $145.82M $147.27M $147.27M
-Gross PPE $142.66M $145.49M $261.56M $259.76M $259.76M
Non-Current Note Receivables $0.00 $0.00 $0.00 $7.38M $7.38M
Goodwill and Other Intangible Assets $10.76M $11.84M $12.89M $13.95M $13.95M
Other Non-Current Assets $37.18M $32.19M $34.98M $18.42M $18.42M
Total Liabilities $1.75B $1.67B $1.52B $1.00B $1.00B
Total Current Liabilities $98.09M $76.73M $67.95M $61.75M $61.75M
Payables $14.87M $13.55M $12.12M $7.38M $7.38M
-Accounts Payable $13.84M $12.00M $11.19M $6.98M $6.98M
-Due to Related Parties Current $1.03M $1.55M $930,000.00 $403,000.00 $403,000.00
Current Accrued Expenses $75.90M $55.67M $34.49M $23.70M $23.70M
Short-Term Debt and Capital Lease Obligation $7.31M $7.51M $7.63M $7.54M $7.54M
-Current Capital Lease Obligation $7.31M $7.51M $7.63M $7.54M $7.54M
Total Non-Current Liabilities $1.66B $1.60B $1.45B $939.72M $939.72M
Long Term Debt and Capital Lease Obligation $862.21M $805.55M $711.53M $510.54M $510.54M
-Long Term Debt $834.94M $774.35M $678.39M $477.09M $477.09M
-Long Term Capital Lease Obligation $27.27M $31.20M $33.15M $33.45M $33.45M
Derivative Product Liabilities $367.19M $376.39M $331.51M $104.14M $104.14M
Other Non-Current Liabilities $427.35M $415.60M $404.77M $325.04M $325.04M
Total Equity -$1.15B -$1.05B -$869.13M -$499.57M -$499.57M
Stockholders' Equity -$1.15B -$1.05B -$870.01M -$500.47M -$500.47M
Capital Stock $106,000.00 $105,000.00 $104,000.00 $101,000.00 $101,000.00
-Common Stock $106,000.00 $105,000.00 $104,000.00 $101,000.00 $101,000.00
Additional Paid-In Capital $3.60B $3.52B $3.46B $3.20B $3.20B
Retained Earnings -$4.77B -$4.59B -$4.36B -$3.73B -$3.73B
Gains/Losses Not Affecting Retained Earnings $26.88M $27.28M $27.45M $28.96M $28.96M
Minority Interests $853,000.00 $868,000.00 $880,000.00 $895,000.00 $895,000.00
-Other Intangible Assets – $11.84M $11.98M $13.04M $13.04M
-Accumulated Depreciation – – -$115.75M -$112.49M -$112.49M
-Goodwill – – $910,000.00 $910,000.00 $910,000.00
Other Current Liabilities – – $2.45M $3.07M $3.07M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$75.33M -$66.49M -$75.36M -$304.94M -$70.38M
Net cash flow from continuing operations -$75.33M -$66.49M -$75.36M -$304.94M -$70.38M
Net Income from Continuing Operations -$184.57M -$230.39M -$632.80M -$351.47M -$61.96M
Gain/Loss from Continuing Operations $17.33M $44.88M $292.88M -$53.32M -$27.18M
Depreciation & Depletion & Amortization $3.89M $4.41M $4.38M $15.53M $3.87M
Other Non-Cash Items $72.73M $345.40M $9.97M $90.58M $8.24M
Change in Working Capital $9.21M -$413,000.00 -$500,000.00 -$54.33M -$14.41M
-Change in Receivables -$126,000.00 -$10.20M -$700,000.00 -$40.21M -$10.56M
-Change in Inventory -$2.69M $1.01M -$4.99M -$6.33M -$7.89M
-Change in Prepaid Assets -$4.09M $1.59M $559,000.00 -$4.86M $3.06M
-Change in Payables and Accrued Expense $18.90M $8.32M $7.04M $2.99M $2.90M
-Change in Other Current Assets -$396,000.00 $336,000.00 -$1.05M $803,000.00 -$16,000.00
-Change in Other Current Liabilities -$1.88M -$2.06M -$1.93M -$7.21M -$1.84M
-Change In Other Working Capital -$504,000.00 $595,000.00 $570,000.00 $477,000.00 -$68,000.00
Net cash flow from investing -$8.04M -$107.47M -$31.65M -$149.80M $43.57M
Net Cash Flow from Continuing Investing Activities -$8.04M -$107.47M -$31.65M -$149.80M $43.57M
Net PPE Purchase and Sale -$2.93M -$3.52M -$1.78M -$3.85M -$903,000.00
Net Intangibles Purchase and Sale $0.00 -$23,000.00 -$11,000.00 -$406,000.00 -$372,000.00
Net Investment Purchase and Sale -$5.12M -$103.93M -$29.86M -$145.55M $44.85M
Financing Cash Flow $53.03M $44.44M $223.93M $400.24M $54.89M
Net Cash Flow from Continuing Financing Activities $53.03M $44.44M $223.93M $400.24M $54.89M
Net Issuance Payments Of Debt $3.05M -$12,000.00 $48,000.00 $2.86M $2.87M
Net Common Stock Issuance $28.40M $45.05M $102.23M $400.56M $53.74M
Proceeds from Stock Option Exercised $21.59M $347,000.00 $47.52M -$2.05M -$590,000.00
Net Other Financing Charges -$3,000.00 -$940,000.00 $74.13M -$1.13M –
Ending Cash Balance $46.36M $76.95M $206.47M $89.43M $89.43M
Net Change in Cash -$30.34M -$129.52M $116.92M -$54.50M $28.09M
Beginning Cash Balance $76.95M $206.47M $89.43M $143.91M $61.34M
Effect of Exchange Rate Changes -$244,000.00 -$3,000.00 $122,000.00 $15,000.00 $5,000.00
Free Cash Flow -$78.26M -$70.03M -$77.15M -$309.19M -$71.65M

Discussion

No comments yet — be the first to weigh in on IBRX.

Sign in to join the discussion.

Scroll to Top